Celularity Inc. (CELU) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. on July 29, 2026, regarding an event that occurred on July 23, 2026. The Company is incorporated in Delaware and its Class A Common Stock trades on the Nasdaq Capital Market under the symbol "CELU".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance matter regarding the Company's stock price.
Material Changes and Events
- Delisting Notice: On July 23, 2026, Celularity Inc. received notice from Nasdaq that it no longer complies with the minimum bid price requirement (Rule 5450(a)(1)).
- Trigger Event: The closing bid price of the Company's Class A common stock fell below $1.00 per share for 30 consecutive business days.
- Current Status: The notice has no immediate effect on the listing; the stock continues to trade on the Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days, until January 19, 2027, to regain compliance.
- Compliance Requirement: To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of 10 consecutive business days prior to the January 19, 2027 deadline.
- Contingency: If compliance is not met by the deadline, the Company may be eligible for an additional 180-day grace period if it meets the market value of publicly held shares and other initial listing standards.
- Risk Factors: Management states there can be no assurance that the Company will regain compliance during the initial period, secure a second grace period, or maintain other listing requirements.
Key Facts for Investor Verification
- Verify the current closing bid price of CELU to assess proximity to the $1.00 threshold.
- Monitor the stock price trajectory over the next 10 consecutive business days to determine if the Company can meet the immediate compliance criteria.
- Review the Company's market value of publicly held shares to determine eligibility for a potential second 180-day grace period.
- Watch for future announcements regarding reverse stock splits or other corporate actions intended to address the bid price deficiency.